首页> Nutrition and Cancer: An International Journal> Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

导出原文传递

翻译打印收藏纠错

第一作者： Ng

作者： Ng ^[1] ; O. ; Keeler ; B. ; Simpson ; J.A. ; Madhusudan ; S. ; Brookes ; M. ; Acheson ; A.

作者单位： National Institute for Health Research (NIHR), Nottingham Biomedical Research Centre, Nottingham ^[1]

发布时间 2020-04-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Nutrition and Cancer

2018年70卷5/8期

1106-1117页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Nutrition and Cancer

2018年70卷5/8期

1106-1117页

检索历史清除

Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

Nutrition and Cancer

相似文献

同项目论文

Nutrition and Cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma

Nutrition and Cancer

相似文献

同项目论文

Nutrition and Cancer

相关期刊

检索历史清除